Actively Recruiting
Robotic Bronchoscopic Ablation Registry for Small Lung Tumors A Long-Term Observational Study of Safety and Outcomes
Led by M.D. Anderson Cancer Center · Updated on 2026-10-09
250
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting and analyzing data from patients diagnosed with lung cancer or metastatic tumors in the lungs who undergo robotic assisted bronchoscopic ablation of peripheral lung tumors. The study aims to assess the safety during and after the procedure, as well as long-term outcomes related to tumor control and patient survival. It also seeks to understand changes seen in imaging over time and to identify factors that may affect safety and cancer outcomes. Participants in this observational study undergo robotic bronchoscopy to ablate small thoracic tumors. Researchers will examine various oncologic outcomes such as local tumor progression, progression-free survival, disease-specific survival, and overall survival. Imaging techniques like chest CT scans will be used before and after ablation to monitor and predict treatment response, including exploring the role of radiomics. During the study, data will be gathered from patients medical records for at least five years and up to ten years following ablation, continuing as part of standard care until death. This information includes safety events such as bleeding or infections, tumor progression assessments, and radiographic changes over time. The study is led by M.D. Anderson Cancer Center and involves long-term monitoring to better understand patient outcomes after this procedure.
CONDITIONS
Brief Title
Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry
Research Team
R
Roberto F Casal, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here